Deeper patient insights for stronger patient outcomes

pharmafile | October 28, 2019 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eyeforpharma, pharma 

Patient insights are crucial. As you already know, they are the key to the creation of successful, targeted programmes and even brand-new product offerings. They dictate the delivery of successful outcomes.

But if we are to gain deeper, richer insights, we must construct frameworks that help more patients articulate their value-drivers and hit on critical touchpoints.

That’s why at eyeforpharma we’ve put together a webinar (2pm GMT/9am EST, 6 November), with an expert panel, to provide pragmatic tools on how to build smarter frameworks for new understanding that leads to targeted, personalised services, and ultimately, greater outcomes.

The panel includes: Daniel De Schryver (Patient Engagement and Advocacy Lead, EMEA, Janssen); Clare Moloney (Programme Insights & Design Lead, IQVIA); Desiree Priestley (Director, Patient Support Strategy & Insights, Otsuka); Oliver Gassner (Head, Digital Health Intelligence, EMEA, Bayer); and Teresa Ferreiro (Patient Advocate & eyeforpharma Award Winner)

By joining, you’ll learn:

  • Why designing frameworks with the patient in mind is insufficient: Work with patients from the beginning to ensure you collect comprehensive and pertinent insights
  • How to build your business case: Use insights to outline the commercial imperative of new services
  • It’s not just patients: When and how to engage HCPs and carers to gather a holistic view on how programmes can best operate

We look forward to a webinar that promises practical advice on how to vastly improve the likelihood of success when building new programmes that deliver maximum patient value.

Registrations are now open here:

*All signups receive the recording – so if you can’t make it on the day, sign up anyway and you’ll get the on-demand version

Related Content

Pfizer sign

Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows

The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed …

Amgen flag

AstraZeneca and Amgen asthma drug shows positive results in Phase III trial

AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority …

India report record number of COVID deaths as bodies drift down Ganges

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 …

Latest content